发布求助
文献互助 智能选刊 最新文献

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy最新文献

筛选
英文 中文
Monoclonal Antibody for Recombinant Histidine Rich Protein 3 (HRP 3) of Plasmodium falciparam. 恶性疟原虫重组富组氨酸蛋白 3 (HRP 3) 的单克隆抗体。
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Pub Date : 2023-12-01 Epub Date: 2021-06-24 DOI: 10.1089/mab.2018.0013
{"title":"Monoclonal Antibody for Recombinant Histidine Rich Protein 3 (HRP 3) of <i>Plasmodium falciparam</i>.","authors":"","doi":"10.1089/mab.2018.0013","DOIUrl":"10.1089/mab.2018.0013","url":null,"abstract":"","PeriodicalId":53514,"journal":{"name":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39106258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report of Graves' Disease in a 45-Year-Old Woman Secondary to Herceptin Treatment for Breast Cancer. 乳腺癌赫赛汀治疗后继发 45 岁女性巴塞杜氏病的病例报告。
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Pub Date : 2023-12-01 DOI: 10.1089/mab.2023.0011
Chinmeri U Achonu, Oluwarotimi B Olopade, Bashir O Yusuf, Abimbola A Fadeyi, Olufemi A Fasanmade
{"title":"Case Report of Graves' Disease in a 45-Year-Old Woman Secondary to Herceptin Treatment for Breast Cancer.","authors":"Chinmeri U Achonu, Oluwarotimi B Olopade, Bashir O Yusuf, Abimbola A Fadeyi, Olufemi A Fasanmade","doi":"10.1089/mab.2023.0011","DOIUrl":"10.1089/mab.2023.0011","url":null,"abstract":"<p><p>Graves' disease is the most common cause of thyrotoxicosis and is characterized by ophthalmopathy with proptosis, chemosis, or conjunctival injection; pretibial myxedema; and thyroid acropachy. It is an autoimmune disease that can be genetic or influenced by coexisting environmental factors such as exposure to anticancer drugs, including immune checkpoint inhibitors. The incidence rate of breast cancer is increasing due to rising awareness of risk factors and screening for breast cancer, and the mortality rate is decreasing due to recent advances in cancer treatment. However, there are side effects that are attributed to these treatment modalities, manifesting in various forms in breast cancer survivors, which are reflected in the patient in this case study.</p>","PeriodicalId":53514,"journal":{"name":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139075803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Characterization of a Novel Neuropilin-2 Antibody for Immunohistochemical Staining of Cancer and Sarcoidosis Tissue Samples. 用于癌症和结节病组织样品免疫组织化学染色的新型Neuropilin-2抗体的开发和表征。
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Pub Date : 2023-10-01 DOI: 10.1089/mab.2023.0007
Sarah Förster, Yeeting E Chong, David Siefker, Yvonne Becker, Ruizhi Bao, Erik Escobedo, Yang Qing, Kaitlyn Rauch, Luke Burman, Christoph Burkart, Philipp Kainz, Andrea Cubitt, Michael Muders, Leslie A Nangle
{"title":"Development and Characterization of a Novel Neuropilin-2 Antibody for Immunohistochemical Staining of Cancer and Sarcoidosis Tissue Samples.","authors":"Sarah Förster,&nbsp;Yeeting E Chong,&nbsp;David Siefker,&nbsp;Yvonne Becker,&nbsp;Ruizhi Bao,&nbsp;Erik Escobedo,&nbsp;Yang Qing,&nbsp;Kaitlyn Rauch,&nbsp;Luke Burman,&nbsp;Christoph Burkart,&nbsp;Philipp Kainz,&nbsp;Andrea Cubitt,&nbsp;Michael Muders,&nbsp;Leslie A Nangle","doi":"10.1089/mab.2023.0007","DOIUrl":"10.1089/mab.2023.0007","url":null,"abstract":"<p><p>Neuropilin-2 (NRP2) is a cell surface receptor that plays key roles in lymphangiogenesis, but also in pathophysiological conditions such as cancer and inflammation. NRP2 targeting by efzofitimod, a novel immunomodulatory molecule, is currently being tested for the treatment of pulmonary sarcoidosis. To date, no anti-NRP2 antibodies are available for companion diagnostics. Here we describe the development and characterization of a novel NRP2 antibody. Using a variety of research techniques, that is, enzyme-linked immunoassay, Western blot, biolayer interferometry, and immunohistochemistry, we demonstrate that our antibody detects all major NRP2 isoforms and does not cross-react with NRP1. Using this antibody, we show high NRP2 expression in granulomas from sarcoidosis patient skin and lung biopsies. Our novel anti-NRP2 antibody could prove to be a useful clinical tool for sarcoidosis and other indications where NRP2 has been implicated. <b><i>Clinical Trial Registration:</i></b> clinicaltrials.gov NCT05415137.</p>","PeriodicalId":53514,"journal":{"name":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71415200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Novel Monoclonal Antibodies Against Nattokinase. 纳豆激酶单克隆抗体的研制。
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Pub Date : 2023-10-01 Epub Date: 2023-10-19 DOI: 10.1089/mab.2023.0012
Takashi Tanikawa, James Yu, Kate Hsu, Shinder Chen, Ayako Ishii, Takami Yokogawa, Yutaka Inoue, Masashi Kitamura
{"title":"Development of Novel Monoclonal Antibodies Against Nattokinase.","authors":"Takashi Tanikawa,&nbsp;James Yu,&nbsp;Kate Hsu,&nbsp;Shinder Chen,&nbsp;Ayako Ishii,&nbsp;Takami Yokogawa,&nbsp;Yutaka Inoue,&nbsp;Masashi Kitamura","doi":"10.1089/mab.2023.0012","DOIUrl":"10.1089/mab.2023.0012","url":null,"abstract":"<p><p>Nattokinase is a protease produced by <i>Bacillus subtilis</i> var. <i>natto</i> that exhibits various beneficial biological effects. Thus, a reliable assay to determine nattokinase levels is needed. In this study, we developed novel mouse monoclonal antibodies (mAbs) that recognize nattokinase, and created a specific and sensitive enzyme-linked immunosorbent assay (ELISA) to measure nattokinase levels. The ELISA was developed using a combination of new mouse antinattokinase mAbs used as capture antibodies coated onto 96-well plates, with a peroxidase-conjugated antibody used for detection. This ELISA enabled detection of nattokinase at 1 ng/mL. We believe that the novel mAbs developed in this study will be useful in future for elucidating nattokinase function.</p>","PeriodicalId":53514,"journal":{"name":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49684935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MAb Targeting a Link Between ExoN and MTase of TGEV NSP14. 靶向TGEV NSP14的外显子N和MTase之间连接的MAb。
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Pub Date : 2023-10-01 Epub Date: 2023-10-19 DOI: 10.1089/mab.2023.0010
Lilan Xie, Fang Lin, Peiling Dong, Yaoming Li
{"title":"MAb Targeting a Link Between ExoN and MTase of TGEV NSP14.","authors":"Lilan Xie, Fang Lin, Peiling Dong, Yaoming Li","doi":"10.1089/mab.2023.0010","DOIUrl":"10.1089/mab.2023.0010","url":null,"abstract":"<p><p>Porcine transmissible gastroenteritis virus (TGEV) infection results in severe gastrointestinal disease manifesting vomiting, diarrhea in neonatal porcine, with extremely high mortality. Monoclonal antibody (MAb) specific to TGEV nonstructural protein (NSP)14 that contains two functional domains, exonuclease (ExoN) and methyltransferase (MTase) domains, may help elucidate the role of NSP14 in the viral life-cycle. In this study, we developed a murine MAb, designated 12F1, against TGEV NSP14 using traditional cell-fusion technique. It was shown the MAb can exclusively bind to viral NSP14, as evidenced by the results of indirect fluorescent assay and western blotting. Intriguingly, epitope screening assay shown that 12F1 targets a hinge region connecting ExoN and N7-MTase of NSP14.</p>","PeriodicalId":53514,"journal":{"name":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621669/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49684936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Where Are We with COVID Boosters? 我们在哪里使用新冠病毒加强剂？
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Pub Date : 2023-10-01 Epub Date: 2023-10-20 DOI: 10.1089/mab.2023.29014.editorial
Thomas Kieber-Emmons
{"title":"Where Are We with COVID Boosters?","authors":"Thomas Kieber-Emmons","doi":"10.1089/mab.2023.29014.editorial","DOIUrl":"10.1089/mab.2023.29014.editorial","url":null,"abstract":"","PeriodicalId":53514,"journal":{"name":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49684937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers. 抗EphB4单克隆抗体在乳腺癌多种应用中的开发。
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Pub Date : 2023-10-01 Epub Date: 2023-10-12 DOI: 10.1089/mab.2023.0015
Ren Nanamiya, Hiroyuki Suzuki, Mika K Kaneko, Yukinari Kato
{"title":"Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers.","authors":"Ren Nanamiya,&nbsp;Hiroyuki Suzuki,&nbsp;Mika K Kaneko,&nbsp;Yukinari Kato","doi":"10.1089/mab.2023.0015","DOIUrl":"10.1089/mab.2023.0015","url":null,"abstract":"<p><p>The erythropoietin-producing hepatocellular carcinoma (Eph) receptors are the largest receptor tyrosine kinase family. EphB4 is essential for cell adhesion and motility during embryogenesis. Pathologically, EphB4 is overexpressed and contributes to poor prognosis in various tumors. Therefore, specific monoclonal antibodies (mAbs) should be developed to predict the prognosis for multiple tumors with high EphB4 expression, including breast and gastric cancers. This study aimed to develop specific anti-EphB4 mAbs for multiple applications using the Cell-Based Immunization and Screening method. EphB4-overexpressed Chinese hamster ovary (CHO)-K1 (CHO/EphB4) cells were immunized into mice, and we established an anti-EphB4 mAb (clone B4Mab-7), which is applicable for flow cytometry, Western blot, and immunohistochemistry (IHC). B4Mab-7 reacted with endogenous EphB4-positive breast cancer cell line, MCF-7, but did not react with EphB4-knockout MCF-7 (BINDS-52) in flow cytometry. Dissociation constant (<i>K</i><sub>D</sub>) values were determined to be 2.9 × 10<sup>-9</sup> M and 1.3 × 10<sup>-9</sup> M by flow cytometric analysis for CHO/EphB4 and MCF-7 cells, respectively. B4Mab-7 detected the EphB4 protein bands from breast cancer cells in Western blot, and stained breast cancer tissues in IHC. Altogether, B4Mab-7 is very useful for detecting EphB4 in various applications.</p>","PeriodicalId":53514,"journal":{"name":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41219919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Monoclonal Antibodies Specific to Either CD300AR111 or CD300AQ111 or Both. 特异于CD300AR111或CD300AQ111或两者的单克隆抗体的开发。
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Pub Date : 2023-10-01 DOI: 10.1089/mab.2023.0017
Hitoshi Koizumi, Chigusa Nakahashi-Oda, Wenxin Lyu, Yumi Yamashita-Kanemaru, Keiji Tabuchi, Kazuko Shibuya, Akira Shibuya
{"title":"Development of Monoclonal Antibodies Specific to Either CD300A<sup>R111</sup> or CD300A<sup>Q111</sup> or Both.","authors":"Hitoshi Koizumi,&nbsp;Chigusa Nakahashi-Oda,&nbsp;Wenxin Lyu,&nbsp;Yumi Yamashita-Kanemaru,&nbsp;Keiji Tabuchi,&nbsp;Kazuko Shibuya,&nbsp;Akira Shibuya","doi":"10.1089/mab.2023.0017","DOIUrl":"10.1089/mab.2023.0017","url":null,"abstract":"<p><p>CD300A is a member of the CD300 immunoglobulin (Ig)-like receptor family consisting of eight molecules in humans, all of which contain one Ig-like domain in the extracellular portion. Upon binding its ligand phosphatidylserine or phosphatidylethanolamine, CD300A mediates an inhibitory signal through the immunoreceptor tyrosine-based inhibitory motif in the cytoplasmic portion. The CD300 family molecules are highly homologous to each other. In addition, CD300A has a single nucleotide polymorphism (rs2272111), which is a nonsense mutation encoding glutamine (CD300A<sup>Q111</sup>) instead of arginine (CD300A<sup>R111</sup>) at residue 111 in the Ig-like domain of CD300A. In this study, we successfully generated monoclonal antibodies (mAbs) specific to either CD300A<sup>R111</sup> or CD300A<sup>Q111</sup> or both. These mAbs are useful for the analysis of CD300A genotype by flow cytometry and the development of an antibody drug for the treatment of various diseases.</p>","PeriodicalId":53514,"journal":{"name":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71415201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of a Novel Anti-Human CCR6 Monoclonal Antibody C6Mab-19 with the High Binding Affinity in Flow Cytometry. 流式细胞术中高结合亲和力抗人CCR6单克隆抗体C6Mab-19的建立
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Pub Date : 2023-08-01 DOI: 10.1089/mab.2023.0004
Tomohiro Tanaka, Kaishi Kitamura, Hiroyuki Suzuki, Mika K Kaneko, Yukinari Kato
{"title":"Establishment of a Novel Anti-Human CCR6 Monoclonal Antibody C<sub>6</sub>Mab-19 with the High Binding Affinity in Flow Cytometry.","authors":"Tomohiro Tanaka,&nbsp;Kaishi Kitamura,&nbsp;Hiroyuki Suzuki,&nbsp;Mika K Kaneko,&nbsp;Yukinari Kato","doi":"10.1089/mab.2023.0004","DOIUrl":"https://doi.org/10.1089/mab.2023.0004","url":null,"abstract":"<p><p>CC chemokine receptor 6 (CCR6) is a member of the G-protein-coupled receptor family that is highly expressed in B lymphocytes, effector and memory T cells, regulatory T cells, and immature dendritic cells. CCR6 has been revealed to have important functions in many pathological conditions, such as cancer, intestinal bowel disease, psoriasis, and autoimmune diseases. The only CCR6 chemokine ligand, CC motif chemokine ligand 20 (CCL20), is also involved in pathogenesis by interacting with CCR6. The CCL20/CCR6 axis is drawing attention as an attractive therapeutic target for various diseases. In this study, we developed novel monoclonal antibodies (mAbs) against human CCR6 (hCCR6) using the peptide immunization method, which are applicable to flow cytometry and immunohistochemistry. The established anti-hCCR6 mAb, clone C<sub>6</sub>Mab-19 (mouse IgG<sub>1</sub>, kappa), reacted with hCCR6-overexpressed Chinese hamster ovary-K1 (CHO/hCCR6), human liver carcinoma (HepG2), and human differentiated hepatoma (HuH-7) cells in flow cytometry. The dissociation constant (<i>K</i><sub>D</sub>) of C<sub>6</sub>Mab-19 was determined as 3.0 × 10<sup>-10</sup> M for CHO/hCCR6, 6.9 × 10<sup>-10</sup> M for HepG2, and 1.8 × 10<sup>-10</sup> M for HuH-7. Thus, C<sub>6</sub>Mab-19 could bind to exogenously and endogenously expressed hCCR6 with extremely high affinity. Furthermore, C<sub>6</sub>Mab-19 could stain formalin-fixed paraffin-embedded lymph node tissues from a patient with non-Hodgkin lymphoma by immunohistochemistry. Therefore, C<sub>6</sub>Mab-19 is suitable for detecting hCCR6-expressing cells and tissues and could be useful for pathological analysis and diagnosis.</p>","PeriodicalId":53514,"journal":{"name":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10076179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of an Expression Vector Engineering Strategy Based on tDNA Insulator Element for the Stable Expression of Vascular Endothelial Growth Factor Receptor-Fc Fusion Protein. 基于tDNA绝缘子元件稳定表达血管内皮生长因子受体fc融合蛋白的表达载体工程策略的建立。
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Pub Date : 2023-08-01 DOI: 10.1089/mab.2023.0006
Azam Rahimpour, Meysam Mosallaei, Farzad Pourghazi, Sayed Hassan Tabatabaee, Reyhaneh Hoseinpoor, Es'hagh Pourmaleki, Mohsen Soosanabadi
{"title":"Development of an Expression Vector Engineering Strategy Based on tDNA Insulator Element for the Stable Expression of Vascular Endothelial Growth Factor Receptor-Fc Fusion Protein.","authors":"Azam Rahimpour,&nbsp;Meysam Mosallaei,&nbsp;Farzad Pourghazi,&nbsp;Sayed Hassan Tabatabaee,&nbsp;Reyhaneh Hoseinpoor,&nbsp;Es'hagh Pourmaleki,&nbsp;Mohsen Soosanabadi","doi":"10.1089/mab.2023.0006","DOIUrl":"https://doi.org/10.1089/mab.2023.0006","url":null,"abstract":"<p><p>During the past decades, tremendous advances have occurred in manufacturing recombinant therapeutic proteins in Chinese hamster ovary (CHO) cells. Nevertheless, the production of stable high-producing cell lines has remained a major obstacle in the development process of the CHO cell line. It has been shown that genomic regulatory elements can promote cell line development efficiency by improving transgenes' productivity and stability. Such elements include insulators, ubiquitous chromatin opening elements, scaffold/matrix attachment regions, and antirepressors. In addition, tDNA elements are shown to act as insulators in mammalian cells. This study examines the effect of the tDNA insulator on stable expression of a vascular endothelial growth factor receptor-Fc fusion protein.</p>","PeriodicalId":53514,"journal":{"name":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10084098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信